-
Operation Warp Speed head Dr. Moncef Slaoui (right) spoke to CNN's Jake Tapper and said he believed on December 11 or 12 the first Americans could get vaccinated - and life could get back to normal by May
-
Pfizer and BioNTech said they will ask the feds for emergency approval of their experimental coronavirus vaccine on Friday.
-
The German laboratory BioNTech works with the American Pfizer. REUTERS / Dado Ruvic / Illustration / File Photo
-
US stocks edged higher on Wednesday, fueled by upbeat news from Pfizer and Boeing.
The Dow Jones industrial average was up 139 points, or 0.5 percent, and was on its way to erase its Tuesday dip. The
-
Moderna's vaccine announcement put Wall Street on pace to build on last week's massive rally sparked by Pfizer's announcement that its experimental vaccine was more than 90 percent effective.
-
Pretty much everything has been said about Covid vaccines. While the American laboratory Pfizer speaks of an efficiency of 90%, and the European Medicines Agency expects the first distributions in January 2021, Midi Libre takes stock of the vaccine race.
-
A doctor closely followed online ensures that the mutations of Covid-19 will make future vaccines useless and evokes a 'scam'. Words that make virus genomics specialists jump.
-
The announcement Sunday at the end of the day of a vaccine candidate '90% effective' is a shock. This announcement also raises many questions. Here are five, to help you see more clearly.
-
In the global race for vaccines against the coronavirus, ten projects have reached phase III of clinical trials, the last stage before obtaining or not obtaining validation from the health authorities, but what are the criteria likely to tip the balance?
-
Pfizer CEO Albert Bourla cashed in on his company’s coronavirus vaccine breakthrough.
The executive sold more than $5.5 million worth of Pfizer stock on Monday — the same day the drugmaker